# Clindamycin 300 mg Capsules in Healthy Subjects Under Fed Conditions

> **NCT00836004** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Clindamycin 300 mg capsule
- **DRUG:** Cleocin HCl 300 mg capsules

## Key facts

- **NCT ID:** NCT00836004
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2003-11
- **Final completion:** 2003-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00836004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00836004, "Clindamycin 300 mg Capsules in Healthy Subjects Under Fed Conditions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00836004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*